Has Shelley Geil received payments from drug or device companies?

Yes. Drug and device makers reported $2,586 in general payments to Shelley Geil across 148 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shelley Geil did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shelley Geil come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shelley Geil

Nurse Practitioner · Vancouver, WANPI 1528147683

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 40.7% of the total. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,586in general payments, 2019–2025

Across 148 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$335
Axsome Therapeutics, Inc.$292
Corium, LLC$179
Alkermes, Inc.$145
Takeda Pharmaceuticals U.S.A., Inc.$118
plus $464 from 10 others

What the payments were for

Food & beverage$2,586100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	82	$1,052
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$335
Axsome Therapeutics, Inc.	10	$292
Corium, LLC	11	$179
Alkermes, Inc.	7	$145
Takeda Pharmaceuticals U.S.A., Inc.	6	$118
Vanda Pharmaceuticals Inc.	4	$109
Otsuka America Pharmaceutical, Inc.	4	$79
Neurocrine Biosciences, Inc.	2	$57
Supernus Pharmaceuticals, Inc.	2	$44
Lundbeck LLC	2	$39
Ironshore Pharmaceuticals Inc.	2	$37
Teva Pharmaceuticals USA, Inc.	1	$35
E.r. Squibb & Sons, L.L.C.	1	$23
Noven Therapeutics, LLC	1	$21
Sunovion Pharmaceuticals Inc.	1	$19

How this compares

$2,586 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.

See all nurse practitioner providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	15	$1,125
Lamotrigine	32	$1,061
Hydroxyzine Pamoate	13	$258
Clonazepam	11	$200
Alprazolam	15	$180
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	11	$169
Zolpidem Tartrate	13	$32

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Vancouver

Bryant MotykowskiVancouver$5K
Olga VoloshinaSeattle$279K
Sandra ChristensenSeattle$244K
Felicia ForrestLynnwood$206K
Amaris MurphyBellevue$146K
Sonia GlennieSeattle$78K
Megan WildesTacoma$72K
Kate KennedyBellevue$63K
Vicki HainesPasco$57K
Jessica ArmitageSumner$46K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →